PNC Financial Services Group’s CG Oncology CGON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$185K Sell
2,728
-342
-11% -$19.4K ﹤0.01% 2380
2025
Q4
$127K Sell
3,070
-204
-6% -$8.44K ﹤0.01% 2650
2025
Q3
$132K Sell
3,274
-5
-0.2% -$145 ﹤0.01% 2611
2025
Q2
$85.3K Buy
3,279
+433
+15% +$10.4K ﹤0.01% 2815
2025
Q1
$69.7K Buy
2,846
+154
+6% +$4.33K ﹤0.01% 2900
2024
Q4
$77.2K Sell
2,692
-27
-1% -$924 ﹤0.01% 2837
2024
Q3
$103K Buy
2,719
+1,074
+65% +$37.7K ﹤0.01% 2657
2024
Q2
$51.9K Buy
+1,645
New +$57K ﹤0.01% 3016

Other funds holding CGON

PNC Financial Services Group's CGON Position: Q1 2026 in Review

PNC Financial Services Group reduced its CG Oncology (CGON) stake by 11% in Q1 2026, selling an estimated $19.4K and leaving 2,728 shares worth $185K. The position accounts for ﹤0.01% of the portfolio, ranked #2380.

PNC Financial Services Group first reported a position in CGON in Q2 2024 and has held it in 8 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • PNC Financial Services Group held 2,728 shares of CG Oncology worth $185K as of Q1 2026.
  • PNC Financial Services Group sold 342 CG Oncology shares in Q1 2026, an estimated $19.4K.
  • CG Oncology made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #2380 holding.
  • PNC Financial Services Group first reported a position in CG Oncology in Q2 2024 and has held it in 8 quarters since.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.